INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 170 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 2.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $624,000 | -29.4% | 42,049 | -5.0% | 0.00% | -25.0% |
| Q2 2021 | $884,000 | +37.9% | 44,259 | +59.5% | 0.00% | +33.3% |
| Q1 2021 | $641,000 | -35.1% | 27,753 | -30.6% | 0.00% | -25.0% |
| Q4 2020 | $988,000 | +51.5% | 40,017 | +154.4% | 0.00% | +33.3% |
| Q3 2020 | $652,000 | -34.3% | 15,730 | -24.1% | 0.00% | -40.0% |
| Q2 2020 | $993,000 | +5.3% | 20,719 | +38.3% | 0.01% | -16.7% |
| Q1 2020 | $943,000 | -49.2% | 14,980 | 0.0% | 0.01% | -33.3% |
| Q4 2019 | $1,856,000 | +278.0% | 14,980 | +102.4% | 0.01% | +200.0% |
| Q3 2019 | $491,000 | +102.9% | 7,400 | +142.9% | 0.00% | +200.0% |
| Q2 2019 | $242,000 | -29.4% | 3,047 | -0.7% | 0.00% | -50.0% |
| Q1 2019 | $343,000 | -49.6% | 3,067 | +6.6% | 0.00% | -71.4% |
| Q2 2014 | $681,000 | – | 2,877 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |